Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients

Dietary methyl group donors could influence the hypermethylation status of certain putative genes. The present study explored the possible associations of dietary intake of one-carbon metabolism-related nutrients with promoter hypermethylation status and expression of retinoic acid receptor-beta (RARB), breast cancer-1 (BRCA1), and Ras association domain family-1, isoform A (RASSF1A) genes in Iranian women with breast cancer (BC). The hypermethylation status was investigated in 146 dissected BC tissue samples using methylation-specific PCR. The expression level was evaluated by real-time RT-PCR. Dietary nutrients were estimated using a validated 136-item food frequency questionnaire. Expression levels of the genes were associated with the unmethylated status of related promoters (p < 0.05). The crude dietary folate and adjusted cobalamin intakes were inversely associated with methylated RARB and BRCA1. Low intake of residual folate and cobalamin was correlated with the methylated status of RARB for subjects at <48 years of age, and folate alone was linked to BRCA1 at >48 years of age. High dietary intake of riboflavin and pyridoxine was the only determinant of the methylated promoter of RARB at odds ratios (ORs) of 4.15 (95 % confidence interval (CI) 1.28–13.50) and 2.53 (95 % CI 1.14–3.83) in multivariate models, respectively. One-carbon nutrients most often correlated inversely with the methylation-influenced expression of RARB. Although high folate intake increased the chance of unmethylation-dependent overexpression of BRCA1 3-fold, cobalamin and methionine were inversely linked to methylation-mediated expression. Nutritional epigenomics less actively influenced RASSF1A. These findings provide new insights into and a basic understanding of the selective contributions of individual B vitamins on hypermethylation and methylation-related expression of RARB and BRCA1 in BC.Key messageHypermethylation at promoters of RARB, BRCA1, and RASSF1A is associated with reduced transcript levels of the respective gene in primary breast cancer tissue samples.Dietary folate and cobalamin intake is inversely associated with methylated RARB and BRCA1.High dietary intake of riboflavin and pyridoxine is associated with increased methylation in the RARB promoter.There is evidence for the age-dependent effects of nutrient intake on promoter methylation status.Bioavailability to the pool of nutrients might determine selectivity.

[1]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[2]  P. Mokarram,et al.  Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status. , 2008, World journal of gastroenterology.

[3]  M. Fackler,et al.  DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma , 2003, International journal of cancer.

[4]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.

[5]  S. Lippman,et al.  Hypermethylation of the Retinoic Acid Receptor-β2 Gene in Head and Neck Carcinogenesis , 2004, Clinical Cancer Research.

[6]  T. Haaf,et al.  Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer , 2012, Human Molecular Genetics.

[7]  S. Edge,et al.  DNA Promoter Methylation in Breast Tumors: No Association with Genetic Polymorphisms in MTHFR and MTR , 2009, Cancer Epidemiology Biomarkers & Prevention.

[8]  B. Christensen,et al.  Breast Cancer DNA Methylation Profiles Are Associated with Tumor Size and Alcohol and Folate Intake , 2010, PLoS genetics.

[9]  Scott M. Williams,et al.  Methyl-group dietary intake and risk of breast cancer among African-American women: a case–control study by methylation status of the estrogen receptor alpha genes , 2003, Cancer Causes & Control.

[10]  M. Singer,et al.  Nutritional Epidemiology , 2020, Definitions.

[11]  Maurice B Loughrey,et al.  BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype , 2008, Breast Cancer Research.

[12]  P. Mehdipour,et al.  The Association of Plasma Folate, Vitamin B12 and Homocysteine Levels on Hypermethylation Status of RARβ2 Gene in Primary Breast Carcinoma , 2009 .

[13]  V. Giguère,et al.  Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells. , 2005, Molecular endocrinology.

[14]  I. Johnson,et al.  Environment, diet and CpG island methylation: epigenetic signals in gastrointestinal neoplasia. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[15]  T. Mikkelsen,et al.  Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.

[16]  P. Mehdipour,et al.  Plasma Total Homocysteine Level in Association With Folate, Pyridoxine, and Cobalamin Status Among Iranian Primary Breast Cancer Patients , 2014, Nutrition and cancer.

[17]  M. Esteller,et al.  DNA methylation profiling in the clinic: applications and challenges , 2012, Nature Reviews Genetics.

[18]  R. L. Baldwin,et al.  BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. , 2000, Cancer research.

[19]  O. Olopade,et al.  Estrogen receptor α, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers , 2007, Breast Cancer Research and Treatment.

[20]  J. Herman,et al.  Hypermethylation in Histologically Distinct Classes of Breast Cancer , 2004, Clinical Cancer Research.

[21]  P. Mehdipour,et al.  The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer , 2010, Cancer Causes & Control.

[22]  H. McNulty,et al.  Low colonocyte folate is associated with uracil misincorporation and global DNA hypomethylation in human colorectum. , 2013, The Journal of nutrition.

[23]  M. Widschwendter,et al.  Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. , 2000, Journal of the National Cancer Institute.

[24]  Z. Nie,et al.  The Association of Retinoic Acid Receptor Beta2(RARβ2) Methylation Status and Prostate Cancer Risk: A Systematic Review and Meta-Analysis , 2013, PloS one.

[25]  Young-In Kim Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  R. Goldbohm,et al.  Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer. , 2008, Carcinogenesis.

[27]  A. Neugut,et al.  The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study , 2011, Epigenetics.

[28]  A. Mcguire,et al.  What is it to be a model? , 2000, HEPAC Health Economics in Prevention and Care.

[29]  Zdenko Herceg,et al.  Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. , 2007, Mutagenesis.

[30]  H. Nijhout,et al.  The relationship between intracellular and plasma levels of folate and metabolites in the methionine cycle: a model. , 2013, Molecular nutrition & food research.

[31]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Sinnett,et al.  Demethylation by 5-aza-2´-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor ß gene in human colon carcinoma cells , 1998, Anti-cancer drugs.

[33]  C. Gerhäuser Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges , 2012 .

[34]  P. Mehdipour,et al.  The biomarker-based validity of a food frequency questionnaire to assess the intake status of folate, pyridoxine and cobalamin among Iranian primary breast cancer patients , 2014, European Journal of Clinical Nutrition.

[35]  S. Sukumar,et al.  Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells , 2000, Oncogene.

[36]  A E Giuliano,et al.  Assessment of DNA methylation status in early stages of breast cancer development , 2013, British Journal of Cancer.

[37]  S. Mirza,et al.  Detection of RASSF1A and RAR? Hypermethylation in Serum DNA from Breast Cancer Patients , 2006, Epigenetics.

[38]  J. Gregory,et al.  Moderate vitamin B-6 restriction does not alter postprandial methionine cycle rates of remethylation, transmethylation, and total transsulfuration but increases the fractional synthesis rate of cystathionine in healthy young men and women. , 2011, The Journal of nutrition.

[39]  C. Davis,et al.  DNA Methylation, Cancer Susceptibility, and Nutrient Interactions , 2004, Experimental biology and medicine.